Clinical Trial Update: Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy, acceptability, and safety of event-driven HIV PrEP with TAF/FTC (Descovy) in men who have sex with men in Thai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV/AIDS | Phase 3 | Status: RECRUITING